viral meningitis: Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2626 |
4. Check minimum number of eventsNone |
2626 |
5. Include endpoints |
2962 |
6. Filter based on genotype QC (FinnGen only) |
2962 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Viral infections of the central nervous system
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26420 | 13206 | 13059 |
| Only index persons | 23392 | 11811 | 11581 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.37 | 0.38 | 0.36 |
| Only index persons | 0.44 | 0.43 | 0.44 |
| Median age at first event (years) | |||
| Whole population | 31.76 | 34.52 | 28.71 |
| Only index persons | 30.31 | 33.40 | 27.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2962 | 1770 | 1192 |
| Unadjusted period prevalence (%) | 0.57 | 0.60 | 0.53 |
| Median age at first event (years) | 35.98 | 34.45 | 38.24 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2713
- Matched controls
- 27127
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A87.9
ICD-10 Finland
Viral meningitis, unspecified
3380.3
323.0
998
5
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
323.0
620
*
0499X
ICD-9 Finland
Other non-arthropod-borne viral diseases of central nervous system, Unspecified non-arthropod-borne viral diseases of central nervous system
+∞
294.2
277
*
04599
ICD-8 Finland
Aseptic mentingitis due to enterovirus, Aseptic meningitis, unspecified
+∞
209.1
198
*
TAB00
NOMESCO Finland
Lumbar puncture
9.7
206.1
448
544
R51.80
ICD-10 Finland
Headache
3.5
123.5
679
2340
AA1AD
NOMESCO Finland
CT of head and brain
3.1
121.3
835
3391
06599
ICD-8 Finland
Viral encephalitis, unspecified
+∞
100.6
96
*
G03.9
ICD-10 Finland
Meningitis, unspecified
51.8
83.2
100
20
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
78.3
353
998
04300
ICD-8 Finland
NA
+∞
68.0
65
*
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
36.5
66.1
85
24
5AB01
NOMESCO Finland
NA
131.0
60.1
64
5
R50.9
ICD-10 Finland
Fever, unspecified
2.6
55.0
473
2067
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
54.3
52
*
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
52.2
50
*
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
+∞
51.2
49
*
A87.8
ICD-10 Finland
Other viral meningitis
507.0
50.6
50
*
04499
ICD-8 Finland
Late effects of actue poliomyelitis
+∞
49.1
47
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
48.9
1097
7217
XA800
NOMESCO Finland
Neuropsychological investigation
4.2
48.9
196
492
04597
ICD-8 Finland
Aseptic mentingitis due to enterovirus, Suspecta
+∞
48.0
46
*
A84.9
ICD-10 Finland
Tick-borne viral encephalitis, unspecified
+∞
48.0
46
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
46.4
470
2220
A87.0
ICD-10 Finland
Enteroviral meningitis
+∞
44.9
43
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
44.2
405
1815
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.9
42.3
143
302
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.5
42.0
206
615
N02AX02
ATC
tramadol; systemic, rectal
1.8
41.7
1081
7346
A89
ICD-10 Finland
Unspecified viral infection of central nervous system
413.6
41.2
41
*
N03AX14
ATC
levetiracetam; systemic
5.4
39.8
124
239
R41.0
ICD-10 Finland
Disorientation, unspecified
5.1
37.1
121
246
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
36.7
190
591
0498X
ICD-9 Finland
Other non-arthropod-borne viral diseases of central nervous system, Other specified non-arthropod-borne viral diseases of central nervous system
+∞
36.5
35
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
35.5
269
1076
A85.8
ICD-10 Finland
Other specified viral encephalitis
+∞
35.5
34
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.1
33.5
135
340
N03AX16
ATC
pregabalin; oral
1.9
32.8
620
3732
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
32.8
546
3145
J05AB11
ATC
valaciclovir; oral
2.2
32.3
381
1906
R42
ICD-10 Finland
Dizziness and giddiness
1.9
32.0
543
3142
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.9
29.8
85
148
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
29.5
936
6563
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
29.2
366
1876
N71
ICPC
Meningitis/encephalitis
151.6
28.7
30
*
H02AB06
ATC
prednisolone; systemic
1.6
28.6
1160
8654
R51
ICD-10 Finland
Headache
2.9
27.6
182
667
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
27.4
540
3270
B00.4
ICD-10 Finland
Herpesviral encephalitis
+∞
27.1
26
*
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
27.1
26
*
B34.9
ICD-10 Finland
Viral infection, unspecified
3.9
26.8
112
293
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
26.3
1168
8851
R4120
NOMESCO Finland
Occupational therapy
2.7
26.2
193
758
J01AA02
ATC
doxycycline; systemic
1.6
25.9
1954
16766
N02BE01
ATC
paracetamol; systemic, rectal
1.7
25.1
2186
19361
A81.0
ICD-10 Finland
Creutzfeldt-Jakob disease
+∞
25.0
24
*
J01DB01
ATC
cefalexin; oral
1.6
24.9
2127
18709
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.1
24.9
56
70
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.7
24.2
84
184
R03AC02
ATC
salbutamol; inhalant
1.5
24.1
1327
10493
N03AX12
ATC
gabapentin; oral
1.9
24.0
403
2303
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
23.9
268
1303
B91
ICD-10 Finland
Sequelae of poliomyelitis
20.8
23.9
35
17
N03AF02
ATC
oxcarbazepine; oral
3.4
23.4
119
366
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
23.3
448
2678
1380A
ICD-9 Finland
Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]
+∞
22.9
22
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
22.8
665
4490
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.1
21.8
86
214
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
21.1
286
1504
M03BX02
ATC
tizanidine; oral
1.5
21.1
1559
12966
A81.2
ICD-10 Finland
Progressive multifocal leukoencephalopathy
+∞
20.9
20
*
F05.9
ICD-10 Finland
Delirium, unspecified
4.8
20.7
70
150
ZX120
NOMESCO Finland
Intravenous
2.1
20.6
247
1236
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
20.5
886
6565
G44.2
ICD-10 Finland
Tension-type headache
1.8
20.1
356
2063
0479X
ICD-9 Finland
Meningitis due to enterovirus, Unspecified viral meningitis
+∞
19.8
19
*
N06AA09
ATC
amitriptyline; systemic
2.0
19.5
248
1272
N05BA01
ATC
diazepam; systemic, rectal
1.8
19.4
336
1928
R53
ICD-10 Finland
Malaise and fatigue
1.7
19.2
502
3276
G41.9
ICD-10 Finland
Status epilepticus, unspecified
10.4
19.1
37
36
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
18.3
19.1
29
16
A02BC02
ATC
pantoprazole; systemic
1.4
19.0
1534
12851
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
19.0
594
4057
G02.0*A87.0
ICD-10 Finland
Enteroviral meningitis
+∞
18.8
18
*
N03AG01
ATC
valproic acid; systemic, rectal
2.3
18.7
182
827
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
100.7
18.6
20
*
J01FF01
ATC
clindamycin; systemic
1.6
18.3
650
4578
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
18.2
219
1099
N03AX18
ATC
lacosamide; systemic
8.6
18.1
39
46
N01
ICPC
Headache
1.9
18.1
293
1642
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
18.1
374
2275
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
18.1
261
1403
N06AX21
ATC
duloxetine; oral
1.9
18.0
275
1510
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
17.8
1280
10432
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
17.8
503
3345
G02.0
ICD-10 Finland
Meningitis in viral diseases classified elsewhere
+∞
17.7
17
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
17.7
330
1941
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
42.3
17.3
21
5
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.1
17.1
198
977
N05CF01
ATC
zopiclone; oral
1.5
16.9
715
5223
J01MA02
ATC
ciprofloxacin; systemic
1.5
16.8
868
6610
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
16.7
98
336
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
16.7
16
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
6.6
16.6
42
64
J01MA12
ATC
levofloxacin; systemic
1.7
16.6
414
2657
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.7
16.5
71
193
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.3
16.5
157
709
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.7
16.3
356
2198
J01DA01
ATC
[U] cefalexin; systemic
1.4
16.3
1536
13061
P01AB01
ATC
metronidazole; oral, rectal
1.4
16.3
945
7355
N02AA05
ATC
oxycodone; systemic
1.8
15.9
296
1738
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
15.9
1133
9148
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
15.9
280
1616
N06AX11
ATC
mirtazapine; oral
1.5
15.9
754
5631
N05BA04
ATC
oxazepam; oral
1.5
15.8
587
4155
A02BC05
ATC
esomeprazole; systemic
1.4
15.7
923
7185
183
Kela drug reimbursment
Lamotrigin and topiramate
6.0
15.7
43
73
N03AF01
ATC
carbamazepine; oral, rectal
2.4
15.7
138
598
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.1
15.7
60
147
N06AB04
ATC
citalopram; systemic
1.6
15.7
512
3518
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
15.6
890
6883
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
15.5
213
1123
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
15.1
649
4740
32099
ICD-8 Finland
Meningitis, With no organism specified as cause
14.0
15.0
25
18
J01FA06
ATC
roxithromycin; oral
1.4
14.9
953
7519
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
14.8
377
2428
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
14.8
304
1839
G43.9
ICD-10 Finland
Migraine, unspecified
2.2
14.7
158
755
04301
ICD-8 Finland
NA
+∞
14.6
14
*
J01FA10
ATC
azithromycin; systemic
1.4
14.3
1464
12501
R11
ICD-10 Finland
Nausea and vomiting
1.9
14.1
200
1067
J02AC01
ATC
fluconazole; systemic
1.4
14.1
947
7521
XA400
NOMESCO Finland
EEG
6.7
14.0
35
53
N06AB10
ATC
escitalopram; oral
1.5
14.0
501
3508
M01AE02
ATC
naproxen; oral, rectal
1.4
13.8
1392
11817
N05BA09
ATC
clobazam; oral
7.8
13.8
31
40
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
4.2
13.7
52
127
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.8
13.7
57
152
04500
ICD-8 Finland
Aseptic mentingitis due to enterovirus, Coxsackie virus
+∞
13.5
13
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.0
13.2
173
897
N03AE01
ATC
clonazepam; systemic
2.1
13.0
141
677
A02BC01
ATC
omeprazole; systemic
1.5
12.8
604
4471
N05AH04
ATC
quetiapine; oral
1.5
12.7
410
2796
J01CA04
ATC
amoxicillin; systemic
1.4
12.7
2060
18784
J05AB01
ATC
aciclovir; systemic
1.5
12.7
490
3483
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
12.5
240
1420
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
12.5
393
2663
04699
ICD-8 Finland
Other enterovirus diseases of central nervous system
+∞
12.5
12
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
17.4
12.5
19
11
120
Kela drug reimbursment
Hypogammaglobulinaemia
17.4
12.5
19
11
M54.5
ICD-10 Finland
Low back pain
1.4
12.4
761
5912
WX892
NOMESCO Finland
Monitored bed care
2.0
12.3
166
869
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.8
12.3
51
136
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
12.3
133
638
R4110
NOMESCO Finland
Physiotherapy
1.4
12.3
574
4240
A02BC03
ATC
lansoprazole; oral
1.4
12.2
620
4652
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
37.7
12.2
15
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
12.2
297
1889
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
12.0
560
4132
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
11.9
179
976
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
11.9
661
5039
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
11.7
514
3743
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
11.5
589
4422
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
11.5
450
3204
G02.0*B02.1
ICD-10 Finland
Zoster meningitis
+∞
11.5
11
*
JN4BD
NOMESCO Finland
Extensive body CT
1.8
11.4
218
1288
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
11.3
174
956
WX730
NOMESCO Finland
Conventional respirator
3.8
11.3
47
126
N06AX16
ATC
venlafaxine; oral
1.6
11.3
340
2279
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
11.2
523
3852
N03AB02
ATC
phenytoin; systemic
4.4
11.2
39
89
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
11.2
147
764
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.9
11.1
35
72
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
11.1
310
2041
R55
ICD-10 Finland
Syncope and collapse
1.7
11.0
220
1320
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
11.0
99
436
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.4
11.0
94
405
M01AB05
ATC
diclofenac; systemic, rectal
1.3
11.0
1583
13974
N03AX09
ATC
lamotrigine; oral
2.1
10.9
124
609
N29
ICPC
Neurological sympt/complt other
3.4
10.8
51
152
H02AB09
ATC
hydrocortisone; systemic
2.9
10.8
65
230
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.5
10.8
37
83
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
10.8
645
4968
J01EA01
ATC
trimethoprim; systemic
1.4
10.7
541
4040
A28
ICPC
Limited function/disability NOS
1.6
10.7
260
1649
3229X
ICD-9 Finland
Meningitis of unspecified cause, Meningitis, unspecified
21.5
10.7
15
7
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.2
10.6
55
176
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
10.6
381
2658
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
10.6
211
1266
H02AB07
ATC
prednisone; oral
1.6
10.6
308
2046
A69.2
ICD-10 Finland
Lyme disease
2.2
10.6
110
521
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.9
10.6
153
827
C01CA24
ATC
epinephrine; parenteral
1.9
10.6
160
875
A02BA02
ATC
ranitidine; systemic
1.5
10.5
394
2772
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
10.5
384
2688
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
10.5
148
791
5CM18
NOMESCO Finland
NA
10.1
10.5
20
20
M25.5
ICD-10 Finland
Pain in joint
1.4
10.5
632
4874
B01AA03
ATC
warfarin; systemic
1.5
10.4
334
2270
B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
10.4
10
*
G03.2
ICD-10 Finland
Benign recurrent meningitis [Mollaret]
+∞
10.4
10
*
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
32.6
10.3
13
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
10.2
422
3031
R06.0
ICD-10 Finland
Dyspnoea
1.4
10.2
494
3662
N99
ICPC
Neurological disease other
4.2
10.1
37
89
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
10.0
614
4748
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
10.0
107
512
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
9.9
345
2386
B01AB05
ATC
enoxaparin; parenteral
1.4
9.9
598
4606
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
9.9
95
435
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
9.9
855
6976
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
9.8
224
1396
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
9.7
157
880
A06AD11
ATC
lactulose; oral
1.6
9.7
270
1776
SPAT1254
SPAT
Administration of medicine
1.5
9.7
315
2149
N70
ICPC
Poliomyelitis
13.4
9.7
16
12
ZXA10
NOMESCO Finland
Bilateral
1.5
9.6
381
2711
N03AX11
ATC
topiramate; oral
2.5
9.6
73
298
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
9.6
327
2254
UJF32
NOMESCO Finland
Coloscopy
1.4
9.5
516
3898
C07AB07
ATC
bisoprolol; oral
1.3
9.5
905
7474
L28
ICPC
Limited function/disability (L)
1.5
9.5
298
2014
N02AC04
ATC
dextropropoxyphene; oral
2.4
9.4
80
343
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
9.4
9
*
C03CA01
ATC
furosemide; systemic
1.4
9.3
492
3700
F05.8
ICD-10 Finland
Other delirium
6.0
9.2
24
40
J01CA08
ATC
pivmecillinam; oral
1.3
9.2
888
7343
SPAT1216
SPAT
Assessment of functional ability
1.5
9.1
289
1958
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.3
9.1
32
75
G41.0
ICD-10 Finland
Grand mal status epilepticus
11.5
9.1
16
14
H02AB04
ATC
methylprednisolone; systemic
1.5
9.0
305
2098
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.9
9.0
126
673
J01FA09
ATC
clarithromycin; systemic
1.3
9.0
732
5899
N30.0
ICD-10 Finland
Acute cystitis
1.5
8.9
292
1990
N05CF02
ATC
zolpidem; oral
1.4
8.9
390
2830
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
8.9
97
468
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
4.2
8.9
32
77
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.4
8.8
30
68
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.9
8.7
132
726
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
8.7
256
1704
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
8.7
103
519
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.0
8.5
108
556
N05BA12
ATC
alprazolam; oral
1.6
8.5
221
1429
J01MA14
ATC
moxifloxacin; systemic
1.7
8.5
179
1094
G03.8
ICD-10 Finland
Meningitis due to other specified causes
90.3
8.4
9
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
8.4
2292
21663
A46
ICD-10 Finland
Erysipelas
1.5
8.4
254
1704
M01AX17
ATC
nimesulide; oral
1.4
8.4
484
3690
R07.3
ICD-10 Finland
Other chest pain
1.6
8.4
199
1257
6BA02
NOMESCO Finland
NA
7.9
8.4
18
23
0632A
ICD-9 Finland
Tick-borne viral encephalitis, Central European encephalitis[PUUTIAISEN VÄLITTÄMÄ ENKEFALIITTI (KUMLINGE)]
+∞
8.3
8
*
A87.2
ICD-10 Finland
Lymphocytic choriomeningitis
+∞
8.3
8
*
B02.1
ICD-10 Finland
Zoster meningitis
+∞
8.3
8
*
G03.0
ICD-10 Finland
Nonpyogenic meningitis
+∞
8.3
8
*
A84.1
ICD-10 Finland
Central European tick-borne encephalitis
+∞
8.3
8
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
8.3
672
5402
R06AE07
ATC
cetirizine; oral
1.3
8.3
1020
8681
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
8.3
120
651
N05CD07
ATC
temazepam; oral
1.6
8.2
239
1584
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
8.2
211
1360
G44.8
ICD-10 Finland
Other specified headache syndromes
3.5
8.2
36
104
R03DC03
ATC
montelukast; oral
1.4
8.1
346
2495
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
8.1
167
1013
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
8.1
411
3065
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
8.0
350
2533
UKC02
NOMESCO Finland
Cystoscopy
1.5
8.0
270
1853
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.5
8.0
60
245
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
8.0
156
934
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.0
7.9
99
509
64090
ICD-8 Finland
Artificial termination of pregnancy performed for medical reasons, Woman's illness or physical defect (medicines. Cause)
4.2
7.9
28
67
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
7.9
146
858
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
7.9
160
969
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.8
7.8
142
829
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.8
908
7658
G81.9
ICD-10 Finland
Hemiplegia, unspecified
3.8
7.7
31
83
M79.6
ICD-10 Finland
Pain in limb
1.3
7.7
763
6298
N28
ICPC
Limited function/disability (N)
3.3
7.7
36
109
G03.1
ICD-10 Finland
Chronic meningitis
45.1
7.7
9
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
6.4
7.7
19
30
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
7.7
283
1983
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.1
7.7
39
126
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.6
7.6
51
196
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
7.6
199
1286
WX110
NOMESCO Finland
Local anesthesy
1.3
7.6
1677
15259
R01AD09
ATC
mometasone; nasal
1.3
7.6
1037
8922
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
7.6
209
1371
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
7.5
402
3020
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
7.5
241
1641
WX704
NOMESCO Finland
Intubation
1.7
7.5
151
913
R47.0
ICD-10 Finland
Dysphasia and aphasia
4.0
7.4
28
71
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.2
7.4
37
118
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
80.3
7.4
8
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.1
7.4
80
389
N05AX08
ATC
risperidone; systemic
1.7
7.3
160
989
N06AA10
ATC
nortriptyline; systemic
2.6
7.3
51
199
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
4.7
7.3
23
49
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
3.2
7.3
36
114
A81.8
ICD-10 Finland
Other atypical virus infections of central nervous system
+∞
7.3
7
*
A87
ICD-10 Finland
Viral meningitis
+∞
7.3
7
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
7.2
149
906
B02.0
ICD-10 Finland
Zoster encephalitis
15.8
7.2
11
7
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
7.2
170
1073
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
7.2
152
930
A88.1
ICD-10 Finland
Epidemic vertigo
20.1
7.1
10
5
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
7.1
656
5357
R25.2
ICD-10 Finland
Cramp and spasm
2.4
7.1
54
224
N06AB03
ATC
fluoxetine; oral
1.5
7.1
264
1853
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
8.8
7.0
14
16
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.0
7.0
90
468
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.1
7.0
36
118
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
7.0
131
775
L17
ICPC
Foot/toe symptom/complaint
1.3
6.9
499
3932
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
6.9
141
855
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.0
6.9
87
448
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.8
6.9
107
597
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.9
1246
11027
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
6.9
87
451
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.9
567
4556
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.2
6.8
63
285
N06AX03
ATC
mianserin; oral
1.9
6.8
93
497
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.2
6.8
33
104
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
6.8
237
1641
L03
ICPC
Low back symptom/complaint
1.3
6.8
500
3952
R29.1
ICD-10 Finland
Meningismus
40.1
6.8
8
*
32309
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Unspecified
40.1
6.8
8
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
16.7
6.7
10
6
A03
ICPC
Fever
1.4
6.7
365
2748
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.7
1116
9777
R03BA02
ATC
budesonide; inhalant
1.4
6.7
380
2881
S06.0
ICD-10 Finland
Concussion
1.5
6.7
224
1537
S20.2
ICD-10 Finland
Contusion of thorax
1.9
6.7
97
527
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
3.4
6.6
30
90
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
7.8
6.6
14
18
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.9
6.6
91
488
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.0
6.6
35
118
S18
ICPC
Laceration/cut
1.3
6.6
839
7125
C08DA01
ATC
verapamil; systemic
2.0
6.6
80
408
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
6.6
124
737
G40
ICD-10 Finland
Epilepsy
3.6
6.6
27
75
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
8.7
6.5
13
15
SPAT1229
SPAT
Assessment of need for aid
1.6
6.5
145
902
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.7
6.5
42
158
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
6.5
185
1224
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
4.0
6.5
24
61
G43.3
ICD-10 Finland
Complicated migraine
2.6
6.5
44
173
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
6.4
81
420
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
6.4
97
537
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
6.4
222
1537
M01AH05
ATC
etoricoxib; oral
1.2
6.4
1326
11879
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
6.3
1262
11247
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
6.3
148
934
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
1.9
6.3
85
454
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
6.3
312
2316
R40.2
ICD-10 Finland
Coma, unspecified
4.0
6.3
23
58
M01AB55
ATC
diclofenac, combinations; oral
1.7
6.3
126
761
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
6.2
6
*
0459X
ICD-9 Finland
Acute poliomyelitis, unspecified[POLIOMYELITIS ACUTA NUD,NUD]
+∞
6.2
6
*
A81.9
ICD-10 Finland
Atypical virus infection of central nervous system, unspecified
+∞
6.2
6
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
6.2
187
1253
P01BA02
ATC
hydroxychloroquine; oral
1.6
6.2
175
1155
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
6.2
112
657
M05BA04
ATC
alendronic acid; oral
1.6
6.2
142
889
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.9
6.2
80
420
C08CA01
ATC
amlodipine; oral
1.3
6.2
622
5120
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
6.2
67
329
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
6.2
66
320
M54.2
ICD-10 Finland
Cervicalgia
1.6
6.2
145
915
G43.8
ICD-10 Finland
Other migraine
2.8
6.2
36
128
M79.1
ICD-10 Finland
Myalgia
1.4
6.2
261
1882
M02AA07
ATC
piroxicam; topical
1.3
6.2
728
6117
G93.4
ICD-10 Finland
Encephalopathy, unspecified
7.7
6.1
13
17
RS221
NOMESCO Finland
NA
2.7
6.1
37
136
W19
ICD-10 Finland
Unspecified fall
1.5
6.1
184
1237
SPAT1301
SPAT
No procedures
1.3
6.1
653
5425
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
6.1
191
1293
R02
ICPC
Shortness of breath/dyspnoea
1.5
6.1
231
1630
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
6.1
567
4629
WX882
NOMESCO Finland
High dependency care
2.3
6.0
53
237
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
2.5
6.0
43
171
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
6.0
215
1499
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
6.0
180
1205
SPAT1263
SPAT
Sampling
1.2
6.0
944
8192
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
425
533
9.14
323.31
1.5
1.4
e6/l
67.2
31.8
1.92
357
408
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
224
96
25.16
315.07
1.4
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
449
493
10.56
307.65
1.5
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
376
198
21.60
307.65
1.3
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
229
84
29.46
307.65
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
319
116
30.70
307.65
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
511
600
10.08
307.65
1.5
1.3
mg/l
666.7
507.6
6.90
488
567
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
301
125
26.69
307.65
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
493
535
10.85
307.65
1.5
1.3
mmol/l
3.6
3.7
0.83
459
500
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
426
533
9.17
307.65
1.6
1.5
e6/l
511.1
1085.0
0.73
365
431
(3016018) Differential panel - Cerebral spinal fluid
293
238
13.55
301.69
1.4
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
244
251
10.50
213.96
1.2
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
239
244
10.57
210.67
1.6
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
143
56
26.78
207.19
1.3
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
147
63
24.50
206.00
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
142
56
26.58
205.21
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
137
51
28.12
202.01
1.2
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
203
180
12.03
196.75
1.5
1.3
mmol/l
2.2
2.0
2.15
192
169
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
142
65
22.90
193.83
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
142
70
21.26
187.93
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
130
63
21.54
173.19
1.3
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
176
172
10.82
159.48
1.2
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
131
85
16.08
152.02
1.2
1.1
ng/l
96.9
324.2
0.82
65
22
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
106
43
25.53
151.31
1.2
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
86
28
31.60
132.06
1.3
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
82
27
31.21
125.43
1.2
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
81
31
26.83
117.86
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
169
236
7.53
115.37
1.8
1.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
67
18
38.06
108.50
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
479
1661
3.25
107.39
2.7
2.4
au/ml
24.0
24.2
0.01
20
111
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
442
1513
3.26
100.90
1.5
1.3
au/ml
30.4
48.9
1.28
13
68
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
60
21
29.14
89.79
1.3
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1026
5745
2.20
83.70
4.9
4.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
179
371
5.07
81.62
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
62
32
19.77
79.98
1.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
248
684
3.87
78.26
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
82
77
10.92
76.01
1.1
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
99
123
8.29
74.45
1.4
1.3
%
84.7
60.5
1.68
38
13
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
59
32
18.79
74.41
1.2
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
50
18
28.24
74.02
1.2
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
85
99
8.81
67.30
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
100
144
7.15
66.19
1.2
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
49
25
19.91
63.42
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
114
212
5.55
58.57
2.0
1.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
40
17
23.84
55.68
1.1
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
38
15
25.65
54.33
1.1
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
149
376
4.12
52.94
1.3
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
45
29
15.74
52.06
1.2
1.2
%
63.6
48.3
—
39
10
(3018677) aPTT in Platelet poor plasma by Coagulation assay
614
3313
2.08
51.33
2.3
2.2
s
29.8
29.7
0.31
596
3204
(3023183) Ammonium ion [Moles/volume] in Plasma
161
445
3.77
50.36
2.3
3.0
umol/l
29.4
35.3
2.25
133
377
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1020
6583
1.84
49.86
2.7
2.1
u/l
206.7
224.1
0.19
973
6215
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
63
74
8.68
49.51
1.5
1.1
%
13.5
22.1
—
27
7
(3005719) IgG [Mass/volume] in Serum or Plasma
389
1772
2.38
49.30
3.6
2.7
g/l
10.0
10.6
1.83
360
1609
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
212
721
3.09
47.79
1.3
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1154
7902
1.75
45.06
7.2
5.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1732
13352
1.72
43.32
5.5
4.6
mmol/l
6.7
6.6
0.36
1635
12421
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
616
3513
1.95
43.26
2.1
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
100
225
4.56
41.19
2.7
2.2
e9/l
1.4
1.2
0.97
58
136
(3006504) Eosinophils/100 leukocytes in Blood
1493
11170
1.68
40.76
7.6
6.0
%
2.6
2.8
2.39
1407
10448
(3019069) Monocytes/100 leukocytes in Blood
1500
11240
1.68
40.67
8.1
6.3
%
8.4
8.5
0.35
1418
10575
(3022096) Basophils/100 leukocytes in Blood
1454
10828
1.67
40.20
7.7
6.1
%
0.7
0.7
0.31
1370
10147
(3032080) INR in Blood by Coagulation assay
1209
8585
1.69
40.04
9.4
8.4
inr
1.2
1.2
0.90
343
2581
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
80
156
5.24
39.00
2.5
2.4
e9/l
0.2
0.2
0.08
70
137
(3002030) Lymphocytes/100 leukocytes in Blood
1530
11603
1.66
38.96
7.8
6.1
%
28.5
28.6
0.06
1439
10875
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1549
11791
1.66
38.81
6.4
5.9
umol/l
10.3
11.2
1.65
1464
11180
(3028433) Virus identified in Specimen by Culture
56
77
7.39
38.60
1.3
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
96
221
4.46
38.43
1.4
1.1
mg/l
52.8
41.0
1.20
79
179
(3031040) Bacteria [#/volume] in Urine by Automated count
1906
15355
1.68
37.82
5.3
4.3
e6/l
2158.4
1771.8
0.07
25
195
(3018010) Neutrophils/100 leukocytes in Blood
1505
11440
1.64
37.36
7.4
5.9
%
56.8
56.8
0.01
1420
10761
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
79
161
5.01
36.64
2.5
2.3
e6/l
558.5
569.6
0.05
69
137
(3001604) Monocytes [#/volume] in Blood
1552
11926
1.63
36.58
7.2
5.8
e9/l
0.6
0.6
1.88
1379
10388
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1336
9892
1.64
36.58
6.8
5.8
mmol/l
1.2
1.2
0.56
1212
8991
(3006315) Basophils [#/volume] in Blood
1555
11959
1.63
36.50
7.2
5.9
e9/l
0.0
0.0
0.15
1382
10410
(3013115) Eosinophils [#/volume] in Blood
1595
12377
1.63
35.82
7.4
6.1
e9/l
0.2
0.2
1.25
1434
10957
(21494815) CD4 cells/100 lymphocytes in Specimen
89
206
4.42
35.39
2.2
2.2
%
44.2
47.6
0.37
17
25
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1444
10961
1.62
35.30
7.7
6.5
mmol/l
1.2
1.2
0.24
1220
9252
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
90
211
4.37
35.21
1.3
1.1
mg/l
318.1
262.9
1.17
77
180
(3019198) Lymphocytes [#/volume] in Blood
1583
12294
1.62
35.16
7.3
5.9
e9/l
2.0
2.0
0.45
1435
10922
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
39
38
10.39
35.14
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
94
232
4.15
34.40
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1143
8282
1.62
33.19
4.2
3.4
ng/l
32.8
42.8
0.77
723
5170
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
41
47
8.83
32.80
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
87
211
4.22
32.59
1.2
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
77
174
4.52
31.57
2.5
2.4
e6/l
713.4
780.9
0.31
33
69
(4027681)
77
176
4.46
31.13
1.4
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
76
176
4.41
30.23
2.4
2.0
%
12.2
13.3
0.33
46
85
(1175426) CD3 cells/100 lymphocytes in Blood
76
178
4.36
29.80
2.5
2.0
%
74.9
74.2
0.17
76
173
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
22
10
22.16
29.57
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
72
165
4.45
29.02
2.6
2.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
279
1377
2.13
28.52
2.2
1.8
g/l
1.2
1.4
0.83
253
1272
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
29
26
11.25
27.57
1.3
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
118
393
3.09
27.51
1.4
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
423
2459
1.84
26.90
1.9
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
699
4700
1.64
26.29
2.9
2.5
e6/l
5.3
6.4
1.37
617
4137
(3013650) Neutrophils [#/volume] in Blood by Automated count
1682
13748
1.52
26.26
10.2
8.9
e9/l
4.2
4.0
1.77
1512
12049
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
979
7132
1.56
26.21
2.8
2.5
u/l
55.9
57.7
0.65
909
6616
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
185
798
2.41
26.07
2.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
416
2430
1.83
25.99
1.9
1.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
68
166
4.17
25.29
1.3
1.1
u/l
1.6
1.1
0.52
35
87
(3014148) Varicella zoster virus Ab [Titer] in Serum
106
349
3.11
25.21
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
857
6127
1.56
24.63
3.5
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1921
16260
1.52
24.54
5.2
4.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2075
17875
1.54
24.22
8.9
7.2
u/l
76.2
77.1
0.47
1965
16862
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
36
51
7.13
24.17
1.4
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1243
9652
1.50
24.13
5.5
4.7
g/l
35.5
36.0
1.91
1164
8991
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
56
122
4.66
24.06
1.2
1.1
miu/ml
1687.1
1564.2
0.30
56
122
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
35
49
7.22
23.74
1.1
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
25
24
10.50
22.68
1.6
2.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
164
716
2.37
22.49
2.7
1.7
g/l
0.2
0.2
0.73
151
675
(3002582) Erythrocytes [#/volume] in Urine
918
6775
1.51
22.37
3.8
3.1
e6/l
134.9
70.4
0.51
730
5173
(3033658) Prothrombin time (PT) actual/Normal
807
5801
1.54
22.21
4.3
3.9
%
92.6
91.8
0.39
787
5646
(3030467) Casts [#/volume] in Urine by Automated count
852
6206
1.52
22.02
3.6
3.0
e6/l
0.3
0.4
2.26
666
4660
(3036481) Cortisol [Moles/volume] in Serum or Plasma
376
2235
1.78
21.97
2.5
2.1
nmol/l
351.1
375.7
1.74
354
2052
(3000060) B lymphocytes [#/volume] in Blood
38
65
5.91
21.35
1.8
2.3
e6/l
265.2
215.7
0.34
23
37
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
165
741
2.30
21.21
2.7
1.6
g/l
1.1
1.2
1.94
156
698
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
27
8
34.04
21.11
1.1
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
23
22
10.53
20.90
1.5
2.5
—
—
—
0
0
(3026782) Osmolality of Urine
634
4387
1.57
20.47
3.1
2.7
mosm/kgh2o
528.4
545.4
1.07
546
3740
(3013707) Erythrocyte sedimentation rate by Westergren method
2012
17485
1.47
20.24
5.0
3.9
mm/h
11.7
11.1
0.92
1896
16270
(3018095) Leukocytes [#/volume] in Urine
1047
8061
1.46
20.19
4.3
3.6
e6/l
59.8
97.7
0.89
774
5602
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
282
1578
1.87
20.00
2.0
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
146
645
2.33
19.50
2.4
2.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
128
534
2.46
19.42
2.0
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
440
2826
1.65
19.24
7.3
5.9
mmol/l
1.0
1.0
0.97
414
2632
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
34
58
5.92
19.16
1.1
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
477
3138
1.62
18.93
2.7
2.4
g/l
2.4
2.4
0.11
436
2919
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
735
5336
1.50
18.79
1.9
1.8
mg/l
0.8
1.1
1.99
533
3985
(3020630) Protein [Mass/volume] in Serum or Plasma
287
1648
1.82
18.71
2.6
2.6
g/l
65.7
66.7
1.25
260
1513
(3024869) Neuronal Ab [Presence] in Serum
27
37
7.35
18.65
1.1
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
525
3552
1.58
18.49
3.8
3.4
mmol/l
0.8
0.8
0.46
486
3322
(3026008) Bacteria identified in Urine by Culture
878
6623
1.46
18.46
3.3
3.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
121
523
2.37
17.01
2.0
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
467
3138
1.58
16.81
1.7
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
137
631
2.23
16.61
2.0
2.1
mg/l
10.5
10.9
0.22
122
583
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
137
632
2.22
16.55
1.8
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
546
3823
1.52
16.30
1.9
1.7
nmol/l
1147.2
1186.7
0.48
422
2913
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
110
469
2.40
15.96
6.2
5.6
iu/ml
424.2
582.9
0.26
12
59
(3028192) IgG subclass 2 [Mass/volume] in Serum
70
238
2.99
15.85
1.4
1.4
g/l
2.6
2.9
0.83
49
160
(3024139) IgG subclass 3 [Mass/volume] in Serum
70
238
2.99
15.85
1.4
1.4
g/l
0.3
0.4
2.54
49
158
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
18
18
10.05
15.81
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
723
5386
1.45
15.80
2.0
1.9
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
70
239
2.98
15.74
1.4
1.4
g/l
5.6
6.7
2.41
50
162
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1102
8858
1.39
15.62
2.2
1.9
pmol/l
97.8
96.4
0.44
588
4671
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
91
359
2.58
15.58
3.2
2.8
u/ml
659.7
2030.5
—
6
22
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
147
718
2.10
15.38
2.2
2.4
ug/l
682.1
402.0
0.57
139
677
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
156
780
2.06
15.34
2.0
2.1
ug/l
1.2
1.7
0.38
133
688
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
748
5643
1.44
15.19
3.1
2.9
ng/l
996.5
1265.9
1.96
607
4737
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
430
2903
1.56
15.06
2.8
2.5
%
22.7
23.3
0.37
367
2494
(4062490)
69
240
2.92
15.03
1.5
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
45
120
3.79
14.94
1.5
1.4
u/l
12.2
13.3
0.32
45
113
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
72
258
2.84
14.86
1.2
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
662
4905
1.45
14.75
1.6
1.5
nmol/l
20.9
20.6
0.20
566
4241
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
223
1275
1.81
14.70
4.5
3.6
mmol/l
1.9
1.6
0.63
167
949
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
586
4244
1.47
14.69
3.7
3.5
ng/l
287.5
443.1
0.66
406
3052
(3022948) Iron [Moles/volume] in Serum or Plasma
488
3414
1.51
14.48
2.7
2.4
umol/l
12.8
13.5
1.20
450
3169
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
92
380
2.47
14.33
2.0
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1901
16793
1.37
14.32
3.6
3.0
u/l
48.8
45.2
1.12
1791
15848
(3018418) pH of Serum or Plasma
837
6502
1.40
14.24
4.7
3.9
ph
7.4
7.4
0.05
170
1244
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
33
72
4.62
14.22
3.2
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
659
4919
1.44
14.02
1.7
1.4
g/l
2.3
2.3
0.20
425
3079
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2598
24310
1.56
13.82
19.6
12.8
mg/l
21.3
22.6
1.29
2208
19023
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
4.2
2.1
—
8
7
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
1.8
0.5
—
9
6
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
1.4
1.3
—
8
9
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
3.1
0.9
—
9
8
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
3.2
3.2
—
8
7
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
1.4
1.5
—
8
8
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
2.6
3.9
—
8
7
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
0.4
0.9
—
8
7
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
15
14
10.76
13.75
1.7
1.6
mg/l
1.4
0.4
—
8
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
43
118
3.68
13.72
1.0
1.0
ng/l
735.3
300.3
1.10
28
80
(3009343) pH of Capillary blood
226
1326
1.76
13.65
4.5
3.6
ph
7.4
7.4
0.12
32
154
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
355
2351
1.58
13.45
4.9
4.2
u/l
233.2
246.1
0.99
342
2221
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
16
17
9.46
13.44
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
227
1340
1.75
13.43
4.5
3.6
kpa
5.2
5.2
0.20
212
1245
(3020779) Urea [Moles/volume] in Serum or Plasma
294
1862
1.64
13.39
9.6
7.7
mmol/l
8.3
9.0
1.43
277
1782
(3037522) Nuclear Ab [Titer] in Serum
471
3325
1.50
13.30
1.4
1.3
titre
653.9
511.6
0.76
95
674
(3021447) Carbon dioxide [Partial pressure] in Venous blood
309
1985
1.62
13.29
4.0
3.7
kpa
5.8
5.8
0.18
299
1929
(3014111) Lactate [Moles/volume] in Serum or Plasma
299
1910
1.63
13.15
6.6
7.1
mmol/l
1.3
1.4
0.11
285
1831
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
15
15
10.05
13.13
1.0
1.0
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
15
15
10.05
13.13
1.7
1.7
mg/l
0.8
0.4
—
8
8
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
42
117
3.63
13.13
1.0
1.0
ng/l
836.1
707.7
0.65
25
77
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
108
498
2.21
13.11
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
101
453
2.27
13.11
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
101
453
2.27
13.11
1.3
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
83
342
2.47
13.03
1.8
1.9
titre
19240.0
1621.8
—
6
11
(3002032) Base excess in Venous blood by calculation
306
1971
1.62
13.01
4.1
3.7
mmol/l
1.7
1.9
0.41
261
1588
(3024980) IgG subclass 4 [Mass/volume] in Serum
91
392
2.36
12.96
1.4
1.7
g/l
0.5
0.8
3.39
64
297
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
217
1280
1.75
12.87
1.7
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
42
119
3.57
12.81
1.0
1.0
ng/l
40.1
43.6
0.17
27
76
(3042936) Bacteria identified in Isolate by Culture
453
3204
1.49
12.63
2.2
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
515
3744
1.45
12.47
3.0
2.6
e6/l
1.3
1.2
0.18
286
2096
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
354
2389
1.55
12.31
6.7
7.8
kpa
5.1
5.1
0.27
337
2282
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
75
303
2.51
12.29
1.6
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
186
1064
1.80
12.25
4.0
4.0
mmol/l
24.2
24.2
0.09
170
971
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
74
298
2.52
12.21
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
353
2385
1.54
12.20
6.8
7.8
mmol/l
1.0
1.1
0.08
286
1853
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
212
1262
1.73
12.17
1.7
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
93
417
2.27
12.10
1.6
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
353
2390
1.54
12.08
6.7
7.7
kpa
12.1
12.6
0.83
334
2284
(3007853) Bacteria identified in Skin by Aerobe culture
396
2756
1.50
11.91
1.8
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
112
546
2.09
11.84
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
181
1038
1.79
11.83
2.0
2.0
u/l
38.3
39.4
0.34
165
937
(3015377) Calcium [Moles/volume] in Serum or Plasma
929
7537
1.34
11.53
3.4
3.3
mmol/l
2.3
2.4
3.03
806
6677
(3012501) Base excess in Blood by calculation
103
495
2.12
11.32
4.3
4.1
mmol/l
2.4
2.6
0.18
68
330
(3019225) pH of Specimen
311
2081
1.55
11.21
5.0
4.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
256
1641
1.61
11.08
3.9
3.1
kpa
4.9
4.7
0.62
246
1586
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
12
11
10.95
11.06
2.0
5.3
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
12
11
10.95
11.06
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
220
1360
1.67
11.00
4.6
5.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1249
10617
1.30
10.97
11.8
9.0
e9/l
0.0
0.0
0.19
1042
8686
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
731
5758
1.36
10.93
2.3
2.1
mg/l
3.0
2.9
0.41
637
4915
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
575
4357
1.40
10.92
1.7
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
115
585
2.00
10.86
1.6
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
79
348
2.30
10.75
1.5
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
274
1803
1.57
10.62
7.4
8.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
756
6013
1.35
10.55
7.0
6.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
971
8008
1.32
10.54
3.4
3.2
u/l
32.6
32.6
0.01
921
7619
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
96
462
2.11
10.53
1.4
1.4
u/ml
99.4
114.5
0.59
21
88
(1616796) Gas panel - Central venous blood
95
457
2.11
10.44
4.2
3.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
215
1340
1.65
10.42
2.4
2.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
155
883
1.80
10.38
2.4
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1259
10770
1.29
10.34
3.1
2.8
ug/l
117.1
111.5
0.43
1159
10044
(3025941) Bacteria identified in Stool by Culture
225
1424
1.63
10.26
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
104
522
2.03
10.21
1.2
1.2
u/ml
298.2
257.8
0.52
69
316
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1145
9693
1.30
10.13
2.6
2.3
nmol/l
75.5
75.9
0.22
1040
8826
(21494814) CD8 cells/100 lymphocytes in Specimen
32
89
3.62
10.08
2.9
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
742
5929
1.34
9.95
2.9
2.5
umol/l
2236.9
4826.4
1.67
658
5211
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
48
173
2.80
9.91
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
51
191
2.70
9.80
2.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
51
191
2.70
9.80
2.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
51
191
2.70
9.80
2.3
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
307
2112
1.51
9.71
7.1
8.3
%
95.6
95.8
0.22
296
2039
(3027945) Reticulocytes/100 erythrocytes in Blood
328
2294
1.48
9.57
3.0
2.7
%
1.9
1.8
0.48
294
2042
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
149
862
1.77
9.50
4.8
3.9
mmol/l
25.3
24.8
1.55
136
807
(3010421) pH of Blood
113
600
1.92
9.47
4.4
3.9
ph
7.4
7.4
0.87
101
488
(3035350) Ketones [Presence] in Urine by Test strip
1335
11603
1.27
9.34
4.1
3.5
estimate
0.0
0.0
0.80
287
2168
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
468
3511
1.40
9.32
3.3
2.8
e6/l
3.2
2.7
0.50
247
1868
(3019550) Sodium [Moles/volume] in Serum or Plasma
2569
24341
1.42
9.26
20.3
14.2
mmol/l
139.3
139.6
7.79
2518
23720
(3015171) Extractable nuclear Ab [Units/volume] in Serum
159
946
1.72
9.19
1.4
1.3
u/ml
0.3
1.0
—
5
83
(3017181) Myelocytes/100 leukocytes in Blood
277
1890
1.51
9.11
5.2
4.2
%
0.9
0.9
0.03
103
501
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
299
2074
1.49
9.08
2.3
2.2
g/l
0.2
0.2
0.05
275
1944
(3014576) Chloride [Moles/volume] in Serum or Plasma
368
2665
1.43
8.94
7.7
6.9
mmol/l
104.6
104.4
0.33
360
2614
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
13
7
18.64
8.93
3.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
162
982
1.69
8.76
4.6
3.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
249
1678
1.53
8.68
3.3
2.7
e9/l
72.4
71.2
0.16
184
1247
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
92
470
1.99
8.65
4.3
3.8
%
56.7
57.3
0.14
92
470
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
67
303
2.24
8.64
1.4
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
105
562
1.90
8.62
2.8
3.4
ratio
2.6
1.6
—
7
51
(3009261) Glucose [Presence] in Urine by Test strip
1341
11735
1.26
8.61
4.1
3.5
estimate
0.0
0.0
1.32
279
2141
(3021879) Hepatitis B virus core Ab [Presence] in Serum
293
2048
1.48
8.56
1.5
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
75
357
2.13
8.53
1.3
1.3
mmol/l
72.8
61.5
1.36
64
286
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
151
906
1.70
8.49
1.7
1.8
g/l
1.5
1.5
0.08
128
792
(3048689) Calprotectin [Mass/mass] in Stool
422
3161
1.39
8.44
2.5
2.4
ug/g
207.3
124.3
0.78
338
2519
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
57
243
2.37
8.43
1.6
1.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
107
582
1.87
8.37
2.8
3.4
mg/l
40.7
52.8
0.31
83
478
(3003327) Ova and parasites identified in Stool by Light microscopy
141
834
1.73
8.35
1.6
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
254
1734
1.51
8.33
5.0
4.0
%
0.5
0.6
0.20
80
366
(3040151) Glucose [Moles/volume] in Capillary blood
54
226
2.42
8.32
7.7
6.1
mmol/l
7.1
7.4
0.22
47
190
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
365
2674
1.42
8.30
2.5
2.7
umol/l
7.9
7.6
0.10
314
2313
(3013512) EKG study
747
6105
1.30
8.29
3.8
3.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2568
24420
1.39
8.24
20.4
14.4
mmol/l
4.0
4.0
0.01
2509
23753
(3034860) Kappa light chains.free [Mass/volume] in Serum
106
580
1.86
8.15
2.8
3.4
mg/l
46.9
65.8
0.64
82
475
(3016650) Hepatitis A virus Ab [Presence] in Serum
84
425
2.00
8.14
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
146
879
1.70
8.12
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1257
10975
1.25
8.05
4.4
4.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
132
775
1.74
8.04
4.0
3.4
g/l
0.4
0.3
0.51
60
334
(3013005) Retinol [Moles/volume] in Serum or Plasma
31
99
3.15
7.95
1.6
2.0
umol/l
1.9
2.0
0.21
31
91
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92
486
1.92
7.89
1.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
58
257
2.28
7.88
2.1
2.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
40
149
2.71
7.83
2.9
2.7
%
38.1
45.0
1.07
15
46
(3021601) Nitrite [Presence] in Urine by Test strip
1321
11625
1.25
7.80
5.5
4.7
estimate
0.0
0.0
0.50
292
2207
(3002173) Hemoglobin [Mass/volume] in Arterial blood
280
1976
1.46
7.79
7.6
8.7
g/l
123.5
122.5
0.32
273
1905
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2025
18694
1.26
7.78
4.4
4.0
pmol/l
14.7
14.7
0.16
1858
17197
(40768797) Stomach Pathology biopsy report
418
3167
1.37
7.77
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
396
2975
1.38
7.75
1.7
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
239
1638
1.50
7.70
3.3
2.8
e9/l
4.1
4.1
0.01
187
1318
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1053
9045
1.25
7.68
4.3
3.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
258
1797
1.48
7.68
5.3
4.2
%
0.1
0.1
0.87
93
462
(3006184) Hemoglobin [Mass/volume] in Capillary blood
88
463
1.93
7.65
2.7
2.2
g/l
132.1
130.3
0.26
54
340
(40767503) Oxygen content in Capillary blood by calculation
84
435
1.96
7.64
3.2
2.4
%
16.4
16.4
0.05
42
211
(3009466) Valproate [Moles/volume] in Serum or Plasma
77
387
2.02
7.62
4.3
5.5
umol/l
349.1
375.6
0.86
70
338
(3029634) Reagin Ab [Titer] in Serum by VDRL
78
394
2.01
7.62
2.4
2.0
titre
14.0
3.4
—
5
9
(3041096) Erythrocytes [Presence] in Urine by Automated
780
6483
1.28
7.47
3.7
3.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
352
2614
1.39
7.38
23.5
22.4
inr
1.2
1.3
0.45
41
377
(40760888) Immunoglobulin light chains.free panel - Serum
82
427
1.95
7.36
2.6
3.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
32
110
2.93
7.27
2.8
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
32
110
2.93
7.27
2.7
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
32
110
2.93
7.27
2.8
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
32
110
2.93
7.27
2.8
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
865
7300
1.26
7.26
2.8
2.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
170
1096
1.58
7.24
8.1
9.9
mmol/l
24.2
24.4
0.21
154
1035
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
24
70
3.45
7.11
3.1
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
48
206
2.35
7.05
3.2
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
673
5527
1.28
7.04
5.5
4.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
637
5196
1.29
7.03
1.7
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
243
1703
1.46
7.02
5.2
4.3
%
0.0
0.5
0.92
82
386
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
18
43
4.21
7.01
1.8
2.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
193
1295
1.52
6.89
7.9
7.4
mmol/l
25.4
24.5
2.77
184
1212
(3022145) Colonoscopy Study observation
343
2566
1.38
6.87
1.3
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
302
2212
1.41
6.86
2.8
2.4
u/l
33.6
59.6
0.64
259
1914
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1881
17327
1.23
6.84
3.6
3.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
125
762
1.67
6.69
1.6
1.6
titre
656.0
136.4
—
5
28
(3019150) Specific gravity of Urine by Refractometry
621
5081
1.28
6.65
4.3
3.8
kg/l
1.0
1.0
0.16
106
734
(3004809) Band form neutrophils/100 leukocytes in Blood
64
318
2.03
6.59
3.9
3.4
%
1.0
1.4
0.87
53
253
(3029937) Albumin [Presence] in Urine by Test strip
740
6193
1.26
6.57
4.5
3.8
estimate
0.0
0.0
1.49
276
2160
(3036489) Thrombin time
142
901
1.60
6.49
1.9
2.3
s
20.7
21.1
0.85
125
795
(3028707) Methadone [Presence] in Urine by Screen method
98
565
1.76
6.43
4.2
3.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
429
3357
1.32
6.40
1.9
1.8
%
1.5
1.4
1.02
374
2993
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
76
407
1.89
6.33
1.8
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2332
22069
1.27
6.31
5.3
4.7
mu/l
1.8
2.1
1.68
2168
20457
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
77
415
1.88
6.29
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
38
155
2.47
6.27
1.1
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
108
646
1.70
6.22
1.4
1.4
ug/g
286.7
299.9
0.28
64
357
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
38
156
2.45
6.19
1.1
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
344
2621
1.35
6.14
4.1
4.1
%
31.5
31.8
0.16
246
1825
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
40
169
2.39
6.13
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
124
774
1.63
6.08
1.7
1.6
iu/ml
0.1
0.3
1.01
19
150
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
40
170
2.37
6.05
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
244
1761
1.42
6.04
2.6
2.3
ug/l
5.6
6.8
0.74
204
1563
(3006922) Hepatitis E virus Ab [Presence] in Serum
39
164
2.40
6.04
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
62
315
1.99
6.03
1.4
1.3
nmol/l
0.2
0.4
—
6
17
(3015235) Bicarbonate [Moles/volume] in Capillary blood
89
509
1.77
6.02
3.3
2.9
mmol/l
24.8
24.8
0.05
81
446
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
681
5697
1.25
5.99
1.4
1.3
u/ml
2.7
1.5
0.70
162
1539
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
168
1130
1.52
5.97
8.6
10.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
664
5544
1.25
5.94
2.7
2.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
90
519
1.76
5.92
1.5
1.2
u/ml
18.2
47.4
2.56
11
51
(3008536) Aspergillus sp Ab [Presence] in Serum
16
40
4.02
5.89
3.2
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
25
85
2.96
5.84
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2640
25454
1.34
5.75
17.0
11.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
57
287
2.01
5.71
1.4
1.3
—
—
—
0
0
(44790049)
53
260
2.06
5.69
1.8
1.5
—
—
—
0
0
(44790048)
53
260
2.06
5.69
1.8
1.5
—
—
—
0
0
(44790047)
53
260
2.06
5.69
1.8
1.5
—
—
—
0
0
(44806118)
53
260
2.06
5.69
1.8
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
108
663
1.65
5.68
3.3
3.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
124
792
1.59
5.56
1.5
1.4
u/l
9.0
9.5
0.16
102
647
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
82
470
1.77
5.53
1.6
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
57
291
1.98
5.50
1.6
1.4
mu/l
33.1
78.8
0.75
52
255
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
563
4655
1.26
5.44
1.6
1.6
pmol/l
31441484.1
30795303.9
0.01
458
3900
(3027273) Bicarbonate [Moles/volume] in Venous blood
147
982
1.52
5.42
3.6
3.2
mmol/l
25.3
25.2
0.14
137
953
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
118
751
1.59
5.38
3.4
1.9
—
—
—
0
0
(3020891) Body temperature
127
823
1.57
5.37
6.8
4.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
84
2.87
5.35
1.8
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
84
2.87
5.35
1.8
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
54
274
1.99
5.31
1.5
1.6
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
54
277
1.97
5.16
1.3
1.4
pmol/l
290.9
343.2
0.37
44
214
(3025130) Human papilloma virus identified in Specimen
65
357
1.84
5.08
1.8
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
707
1.59
5.07
2.3
2.3
g/l
9.5
10.3
0.96
93
605
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
30
122
2.47
5.04
1.5
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
30
122
2.47
5.04
1.5
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
87
2.77
5.04
3.3
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
87
2.77
5.04
3.3
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
789
6822
1.21
4.96
3.9
3.3
mmol/l
7.5
7.7
0.52
684
5801
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
113
727
1.58
4.95
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
24
88
2.74
4.94
3.5
1.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
142
2.34
4.91
1.5
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
240
1791
1.37
4.91
6.4
3.7
mmol/l
1.2
1.2
0.82
212
1545
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
106
674
1.59
4.89
1.4
1.2
u/ml
16.4
33.7
—
6
37
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
168
1179
1.45
4.89
2.5
2.3
u/l
1760.2
5447.4
2.84
57
458
(1001926) Buprenorphine [Presence] in Urine by Screen method
151
1039
1.48
4.86
3.6
2.2
—
—
—
0
0
(4198724)
33
143
2.32
4.84
1.3
1.9
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
127
844
1.53
4.83
3.3
6.0
%
1.6
1.6
0.04
120
788
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
211
1546
1.39
4.83
3.0
3.2
pmol/l
4.3
4.5
2.54
188
1383
(3000494) Fungus identified in Specimen by Culture
349
2761
1.30
4.79
1.6
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
28
113
2.49
4.79
1.8
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
1740
16171
1.18
4.78
3.7
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1053
9379
1.19
4.77
2.2
2.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
45
223
2.03
4.76
4.9
3.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
173
1229
1.43
4.72
3.6
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
184
1323
1.42
4.70
3.4
2.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
39
184
2.13
4.69
1.2
1.2
titre
75.7
219.5
—
7
40
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
98
618
1.61
4.69
1.4
1.2
u/ml
11.3
2.3
0.54
14
63
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
14
38
3.70
4.64
2.4
4.2
umol/l
37.1
39.4
0.18
14
29
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
763
1.54
4.64
2.3
2.3
g/l
3.8
3.8
0.06
83
553
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
764
1.54
4.61
2.3
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
764
1.54
4.61
2.3
2.3
g/l
7.3
7.4
0.30
86
584
(3007930) Methemoglobin/Hemoglobin.total in Blood
126
845
1.51
4.61
3.6
6.1
%
0.9
0.9
0.25
120
792
(3028300) Cannabinoids [Presence] in Urine
184
1328
1.41
4.61
3.5
2.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
160
1126
1.44
4.60
2.3
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
182
1314
1.41
4.55
3.5
2.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
112
736
1.54
4.51
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
27
111
2.45
4.46
1.8
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
77
463
1.68
4.45
4.4
3.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
105
682
1.56
4.45
4.2
7.0
mmol/l
1.3
1.3
0.02
88
596
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
98
627
1.58
4.43
1.4
1.2
u/ml
16.1
8.7
0.31
18
104
(3042517) Benzodiazepines panel - Urine
12
30
4.01
4.43
2.8
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
217
1622
1.36
4.42
3.8
3.9
ng/l
84.9
83.4
0.09
185
1420
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
116
772
1.52
4.41
2.1
2.4
%
96.8
92.3
1.35
111
720
(3027944) Amphetamines [Presence] in Urine
179
1298
1.40
4.38
2.5
2.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
35
3.73
4.36
2.2
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
112
742
1.53
4.35
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
217
1626
1.36
4.35
1.4
1.3
u/ml
213.6
209.7
0.02
200
1499
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
101
655
1.56
4.32
2.5
2.4
g/l
0.8
1.0
0.23
84
579
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
94
601
1.58
4.28
2.4
2.2
g/l
37.5
37.8
0.14
79
522
(3001964) Herpes simplex virus Ag [Presence] in Specimen
18
61
2.96
4.28
1.4
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
40
198
2.03
4.28
3.6
3.3
%
55.3
54.9
0.03
29
133
(3034770) Mitochondria Ab [Titer] in Serum
101
658
1.55
4.24
1.2
1.3
titre
890.0
1257.0
—
5
20
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
66
386
1.73
4.24
1.2
1.2
u/ml
5.0
5.0
0.01
26
166
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
52
283
1.85
4.24
1.3
1.3
nmol/l
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
27
114
2.38
4.23
1.6
1.7
nmol/l
1.4
5.1
1.10
17
93
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
293
2305
1.30
4.21
4.1
3.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
24
96
2.51
4.21
2.8
2.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
179
1311
1.39
4.14
9.6
9.5
%
94.0
93.9
0.06
179
1303
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
47
250
1.89
4.11
1.5
2.2
mg/l
17.5
24.0
0.63
11
75
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
51
279
1.84
4.10
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
177
1297
1.39
4.09
4.4
3.2
g/l
125.5
130.0
1.87
172
1269
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
36
175
2.07
4.05
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
36
175
2.07
4.05
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
36
175
2.07
4.05
1.4
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
474
3968
1.23
4.04
3.2
2.9
mmol/l
2.4
2.4
0.20
401
3481
(3000093) Morphology [Interpretation] in Blood Narrative
39
196
2.00
4.02
1.1
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
142
1005
1.43
4.00
4.7
2.8
%
1.4
1.3
0.66
142
999
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
85
540
1.59
4.00
2.5
2.3
g/l
0.0
0.0
0.00
77
499
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
26
111
2.35
3.99
1.6
1.6
iu/ml
—
1075877.3
—
0
11
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
32
150
2.15
3.96
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
85
543
1.58
3.91
2.5
2.3
g/l
0.0
0.0
0.00
77
500
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
99
655
1.53
3.91
2.7
3.2
u/ml
0.4
0.3
0.35
54
361
(3039000) Anion gap in Blood
77
481
1.62
3.89
4.3
8.5
mmol/l
11.2
11.3
0.08
71
434
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
721
1.50
3.88
2.3
2.3
g/l
3.2
3.1
0.26
84
567
(3024891) Influenza virus A+B Ag [Presence] in Specimen
106
713
1.50
3.88
1.2
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
77
482
1.61
3.86
4.3
8.5
mmol/l
104.5
105.3
0.70
71
435
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
19
71
2.69
3.82
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
129
906
1.44
3.81
4.5
3.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
693
6057
1.19
3.75
3.6
3.3
mg/l
457.6
383.8
0.14
445
3804
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
120
835
1.46
3.72
1.3
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
89
582
1.55
3.72
2.4
2.2
g/l
0.0
0.0
0.74
81
537
(3034274) Bile acid [Moles/volume] in Serum --fasting
59
348
1.71
3.72
2.2
2.5
umol/l
5.8
6.1
0.09
36
259
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
498
4225
1.21
3.72
1.3
1.3
iu/ml
33.0
29.8
0.21
145
1320
(3026389) Candida sp identified in Specimen by Organism specific culture
55
319
1.74
3.68
1.2
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
229
1776
1.31
3.68
2.7
2.2
nmol/l
12.8
13.1
0.20
216
1595
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
52
297
1.76
3.67
2.3
2.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
60
359
1.69
3.60
1.4
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
474
4018
1.21
3.56
1.3
1.2
u/ml
7.3
10.4
0.67
174
1633
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
173
1.98
3.43
1.5
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
173
1.98
3.43
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
34
173
1.98
3.43
1.5
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
64
396
1.63
3.40
1.6
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
17
64
2.67
3.39
2.6
3.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
213
1656
1.31
3.38
2.0
1.9
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
20
82
2.45
3.38
2.7
2.9
umol/l
29.4
29.4
0.00
15
61
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
18
70
2.58
3.38
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
40
218
1.85
3.31
2.7
3.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
66
415
1.60
3.30
4.2
3.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
322
2645
1.24
3.28
8.9
6.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
254
2031
1.27
3.26
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
149
2.02
3.25
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
49
287
1.72
3.21
2.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
38
3.17
3.21
2.2
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
214
1679
1.30
3.19
3.0
2.9
ng/l
188.4
185.4
0.02
191
1519
(3051651) Icteric interference index of Serum or Plasma
28
137
2.05
3.16
2.7
3.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
57
351
1.64
3.11
3.6
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
56
344
1.64
3.09
2.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
48
283
1.71
3.09
2.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
48
283
1.71
3.09
2.0
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
50
2.81
3.08
1.2
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
253
2042
1.26
3.02
4.9
3.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
48
285
1.70
3.02
2.0
1.4
—
—
—
0
0
(4024509)
34
183
1.87
2.96
1.9
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
48
287
1.68
2.95
2.0
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
58
365
1.60
2.93
1.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
47
282
1.68
2.86
2.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
55
344
1.61
2.85
1.2
1.2
u/l
58.2
37.3
0.27
47
290
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
61
393
1.56
2.80
1.5
1.4
u/l
18.3
23.7
0.90
53
326
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
62
401
1.56
2.80
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
30
158
1.91
2.80
1.3
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2330
22528
1.16
2.79
16.1
11.6
ml/min/173m2
86.4
85.3
1.47
2018
18497
(3020682) Albumin/Creatinine [Ratio] in Urine
711
6369
1.15
2.75
4.5
4.0
mg/mmol
9.8
9.2
0.13
452
4021
(40765096) Chromosome analysis panel by Banding
16
66
2.43
2.70
1.4
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
66
2.43
2.70
1.4
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
76
519
1.48
2.69
1.7
1.7
e6/l
11976.9
11990.6
0.00
55
384
(3037756) Immunofixation for Serum or Plasma
62
406
1.54
2.67
1.3
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
385
3298
1.19
2.60
2.2
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
25
127
1.98
2.60
1.2
1.4
nmol/l
139.8
135.1
0.19
25
127
(3027923) C peptide [Moles/volume] in Serum or Plasma
25
127
1.98
2.60
1.4
1.4
nmol/l
1.2
1.3
0.11
16
100
(3018405) Lactate [Moles/volume] in Arterial blood
101
733
1.39
2.58
5.8
3.8
mmol/l
1.3
1.4
0.70
101
723
(44816559) Phosphatidylethanol [Mass/volume] in Blood
76
525
1.46
2.55
1.4
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
63
420
1.51
2.52
1.1
1.2
—
258.3
—
0
12
(3042111) Morphology [Interpretation] in Bone marrow Narrative
53
340
1.57
2.51
1.7
1.6
—
—
—
0
0
(3000492) Spirometry study
296
2484
1.21
2.50
1.4
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
41
247
1.67
2.49
1.3
1.4
mosm/kgh2o
276.9
280.6
0.40
31
184
(4306422)
59
389
1.53
2.49
1.2
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
11
39
2.83
2.47
1.3
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
339
2891
1.19
2.42
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
33
189
1.75
2.41
1.2
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
30
167
1.80
2.40
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
422
3671
1.17
2.39
2.3
2.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
8
6.26
2.37
4.2
2.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
34
198
1.73
2.35
2.9
2.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
251
2086
1.22
2.35
2.1
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
31
176
1.77
2.34
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
59
395
1.50
2.33
1.1
1.1
—
—
—
0
0
(4211845)
21
105
2.01
2.30
3.7
3.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
132
1020
1.31
2.28
2.2
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
78
555
1.42
2.27
1.3
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
12
47
2.56
2.27
1.3
1.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
86
2.10
2.22
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
20
100
2.01
2.20
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
219
1809
1.23
2.19
3.9
3.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
596
5358
1.14
2.16
3.9
3.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
19
94
2.03
2.15
3.8
3.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
28
159
1.77
2.13
2.3
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
116
890
1.32
2.13
1.5
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
11
43
2.56
2.09
1.8
2.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
260
1.58
2.09
1.7
1.6
%
66.4
58.5
0.68
27
164
(3047007) Chlamydophila sp Ab [Presence] in Serum
57
389
1.47
2.09
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
57
389
1.47
2.09
1.2
1.2
u/ml
4.6
4.4
0.05
17
126
(4035726)
228
1905
1.21
2.05
1.5
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
19
96
1.99
2.05
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
15
69
2.18
2.04
1.8
1.3
nmol/l
64.0
138.3
—
9
53
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
12
50
2.41
2.02
1.3
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2363
23010
1.13
2.02
17.9
13.6
%
39.7
40.2
1.80
1720
17575
(3002523) Influenza virus A Ag [Presence] in Specimen
68
484
1.41
2.01
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
68
484
1.41
2.01
1.2
1.1
—
—
—
0
0
(4010399)
192
1583
1.23
1.98
1.5
1.4
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
11
4.55
1.94
1.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
43
282
1.53
1.92
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
35
219
1.61
1.91
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2630
25821
1.17
1.89
12.6
9.6
u/l
27.4
26.8
0.81
2548
25030
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
213
1787
1.21
1.86
1.3
1.2
iu/ml
99.1
161.6
1.82
75
678
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
72
2.09
1.86
1.6
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
27
159
1.70
1.85
2.3
1.7
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
17
3.53
1.83
3.0
2.2
mg/l
3.5
3.9
—
6
17
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
219
2584
0.84
1.82
1.6
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
855
9194
0.90
1.81
2.6
2.6
—
—
—
0
0
(3024471) HLA-A [Type]
16
80
2.01
1.79
1.0
1.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
133
1067
1.26
1.78
2.0
1.6
mu/l
273.6
293.6
0.46
121
960
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
18
3.34
1.74
1.5
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
36
2.50
1.74
1.0
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
54
2.23
1.73
1.4
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
18
96
1.88
1.70
2.0
2.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
62
2.10
1.65
1.3
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
43
2.33
1.60
1.3
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
43
2.33
1.60
1.3
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
43
2.33
1.60
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
29
182
1.60
1.60
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2202
21453
1.10
1.56
5.7
5.2
mmol/mol
39.6
39.1
1.25
2043
20060
(3035933) Granulocytes/100 leukocytes in Blood
16
85
1.89
1.54
1.3
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
28
176
1.60
1.54
2.6
2.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
15
78
1.93
1.54
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
100
793
1.27
1.51
1.9
1.8
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
27
2.60
1.51
1.3
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
52
375
1.39
1.50
3.6
3.2
nmol/l
1.0
0.8
0.33
38
292
(3004716) Salmonella sp identified in Stool by Organism specific culture
166
1393
1.20
1.50
1.3
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
26
162
1.61
1.49
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2086
21411
0.91
1.48
21.7
16.1
g/l
333.1
332.9
0.43
2067
21241
(3020191) Ethanol [Moles/volume] in Serum or Plasma
32
211
1.52
1.45
1.3
1.5
promille
1.6
1.3
0.48
25
170
(40768446) Kidney Pathology biopsy report
16
88
1.82
1.41
1.9
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
76
589
1.30
1.39
1.4
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
29
2.42
1.39
1.3
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
22
134
1.65
1.39
1.8
1.5
umol/l
27.3
26.1
0.06
22
126
(4015189)
11
53
2.08
1.38
3.2
2.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
91
725
1.26
1.35
1.1
1.1
u/ml
4.0
3.8
—
5
102
(40768443) Skin Pathology biopsy report
116
953
1.23
1.32
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
334
2994
1.13
1.31
1.5
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
24
2.50
1.30
1.3
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
162
1379
1.18
1.28
1.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
18
2.78
1.28
1.2
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
17
99
1.72
1.27
3.9
3.3
ph
7.4
7.4
—
8
29
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
45
328
1.38
1.26
1.3
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
21
131
1.61
1.23
2.0
2.5
%
96.1
97.2
0.05
21
124
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
22
139
1.59
1.23
1.1
1.1
u/ml
3.2
31.1
—
6
15
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
49
2.04
1.22
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
49
2.04
1.22
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
49
2.04
1.22
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
49
2.04
1.22
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
52
392
1.33
1.19
1.1
1.1
iu/ml
12.7
1338.2
0.56
13
102
(3034426) Prothrombin time (PT)
15
86
1.75
1.19
1.1
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2332
22879
1.09
1.16
4.5
4.1
mmol/l
5.9
5.9
1.18
2125
21058
(3002385) Erythrocyte distribution width [Ratio]
2105
20566
1.08
1.16
20.8
15.5
%
13.6
13.6
0.17
2065
20120
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
357
0.67
1.16
1.3
1.4
mmol/l
5.9
7.1
1.56
14
260
(3020491) Glucose [Moles/volume] in Blood
27
182
1.49
1.15
1.8
2.0
mmol/l
7.0
6.8
0.17
21
126
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
152
1766
0.85
1.13
1.4
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
17
103
1.65
1.12
2.8
2.4
—
—
—
0
0
(4268621)
37
267
1.39
1.12
2.0
2.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
51
1.96
1.11
2.4
1.7
—
—
—
0
0
(44806071)
7
31
2.26
1.10
1.1
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
32
2.19
1.08
2.3
2.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
23
153
1.51
1.06
1.2
1.1
ratio
1.0
1.0
—
6
66
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
110
926
1.20
1.03
1.3
1.3
miu/ml
196.4
221.9
0.29
44
444
(21494755) Public health laboratory ask at order entry panel
267
2962
0.89
1.03
1.3
1.3
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
22
2.27
1.03
1.4
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
34
2.06
1.03
2.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
83
1.69
1.01
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
114
966
1.19
1.00
1.6
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
33
239
1.38
1.00
1.6
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
10
176
0.57
1.00
1.3
1.3
—
1.5
—
0
9
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
61
485
1.26
0.99
2.7
2.2
nmol/l
0.9
0.8
0.12
52
410
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
133
0.53
0.98
1.3
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
36
1.95
0.97
5.9
6.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
50
1.80
0.96
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
463
4303
1.09
0.95
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
75
614
1.23
0.95
1.4
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
53
668
0.79
0.94
1.4
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
27
2.22
0.93
1.2
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
93
1103
0.84
0.93
4.0
3.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
28
2.15
0.91
2.0
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
78
1.67
0.91
2.9
4.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
18
118
1.53
0.90
1.8
1.8
u/field
1.1
3.8
1.13
11
89
(3039443) Prostate specific Ag panel - Serum or Plasma
33
440
0.75
0.90
1.5
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
28
202
1.39
0.89
1.1
1.4
titre
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
176
1562
1.13
0.87
1.3
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
17
111
1.53
0.87
2.2
3.6
mg/l
7.5
8.4
0.28
12
93
(3017704) Immunofixation for Urine
17
111
1.53
0.87
1.1
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
49
387
1.27
0.86
1.5
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
54
669
0.80
0.85
1.4
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
45
1.78
0.84
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
67
551
1.22
0.84
1.4
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
179
1.40
0.84
6.4
3.6
%
11.0
11.2
0.06
25
179
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
302
2772
1.10
0.83
1.7
1.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
17
113
1.51
0.82
1.0
1.1
%
95.8
93.5
0.15
17
90
(21494890) Protein electrophoresis panel - 24 hour Urine
27
197
1.37
0.82
3.2
2.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
197
1.37
0.82
1.7
1.4
%
24.3
34.0
0.72
17
124
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
105
1.53
0.81
1.8
1.9
umol/l
29.0
29.4
0.05
16
100
(3042733) HLA Ab [Presence] in Serum
13
81
1.61
0.81
5.5
4.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
22
155
1.42
0.81
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
43
543
0.79
0.81
2.4
2.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
56
685
0.81
0.80
1.4
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
16
106
1.51
0.78
1.5
3.2
umol/l
184.8
162.6
—
8
63
(3004451) EKG impression Narrative
16
106
1.51
0.78
1.6
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
149
1321
1.13
0.78
1.4
1.3
iu/l
24.4
26.0
0.25
126
1118
(40768800) Prostate Pathology biopsy report
22
303
0.72
0.76
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
186
0.64
0.76
1.2
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
174
1.38
0.76
1.5
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
74
876
0.84
0.76
1.4
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
26
346
0.75
0.73
1.1
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
30
228
1.32
0.72
3.1
4.6
u/ml
12.8
82.4
—
6
69
(40758292) HTLV I+II Ab panel - Serum
7
39
1.80
0.72
1.4
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
106
924
1.15
0.72
1.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
34
264
1.29
0.71
3.3
2.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
170
1530
1.12
0.71
1.6
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
198
1801
1.11
0.69
2.4
2.5
ml/min/173m2
71.9
70.2
0.19
75
686
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
128
1136
1.13
0.68
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
22
161
1.37
0.68
1.0
1.0
u/ml
0.3
2.8
—
10
52
(3007461) Platelets [#/volume] in Blood
2750
27305
1.10
0.66
26.7
18.7
e9/l
256.5
254.8
0.66
2700
26667
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
78
1.54
0.65
1.4
1.1
%
94.6
91.8
—
7
40
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
23
171
1.35
0.65
1.1
1.1
iu/ml
11.2
11.7
—
7
46
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
223
2048
1.10
0.65
3.8
4.1
ug/l
12.5
21.3
0.67
171
1651
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
95
1.48
0.64
6.4
3.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
29
1.73
0.64
2.6
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
167
1515
1.11
0.63
3.4
2.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
2751
27324
1.10
0.62
26.5
18.6
fl
90.6
90.6
0.05
2718
26977
(4094501)
70
599
1.17
0.62
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
62
525
1.18
0.62
1.0
1.1
u/ml
8.8
5.1
0.85
38
279
(3035941) MCH [Entitic mass]
2751
27325
1.09
0.62
26.5
18.6
pg
30.2
30.2
0.02
2718
26975
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
49
1.63
0.62
1.0
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
51
1.57
0.60
4.6
2.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
75
648
1.16
0.60
1.7
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2751
27330
1.09
0.60
26.6
18.7
e12/l
4.5
4.5
2.74
2696
26632
(3044242) Glucose [Moles/volume] in Arterial blood
15
105
1.43
0.60
1.6
2.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
80
1.50
0.59
1.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
6.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
22
166
1.33
0.58
1.4
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2751
27336
1.09
0.57
26.7
18.7
e9/l
6.9
6.7
4.08
2696
26636
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
167
1.32
0.56
2.5
2.2
u/field
2.3
1.9
—
8
74
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
16
115
1.39
0.56
1.1
1.2
u/l
11.8
11.3
0.05
16
102
(40768795) Lymph node Pathology biopsy report
27
212
1.28
0.55
1.1
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
70
804
0.87
0.54
1.4
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2751
27342
1.09
0.54
26.8
18.8
g/l
135.2
136.3
3.71
2718
26989
(3004616) Nuclear Ab [Presence] in Serum
34
276
1.23
0.54
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
108
967
1.12
0.53
1.5
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
30
240
1.25
0.53
4.1
2.2
pg
33.7
32.2
1.18
30
240
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
70
802
0.87
0.53
1.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
22
169
1.30
0.53
1.5
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
25
196
1.28
0.52
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
14
100
1.40
0.51
1.8
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
75
1.47
0.50
1.0
11.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
92
1.41
0.50
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
41
1.46
0.50
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
633
6096
1.05
0.49
1.7
1.6
mmol/l
1.4
1.4
0.54
525
5220
(3005011) Chlamydia sp Ab [Titer] in Serum
7
45
1.56
0.49
1.7
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2301
22770
1.05
0.48
3.9
3.7
mmol/l
1.4
1.3
2.22
2111
21113
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
71
805
0.88
0.48
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
26
208
1.25
0.48
4.2
3.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
71
804
0.88
0.47
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
51
439
1.16
0.46
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
49
1.43
0.46
1.4
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
12
86
1.40
0.44
1.4
1.8
%
150.3
153.1
0.05
12
79
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
41
348
1.18
0.44
1.0
1.0
u/ml
0.2
0.4
—
10
84
(3023430) Cat dander IgE Ab [Units/volume] in Serum
43
367
1.17
0.44
1.0
1.0
u/ml
4.1
4.4
0.06
19
151
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
22
175
1.26
0.43
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
113
1.33
0.42
1.3
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
113
1.33
0.42
1.3
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
32
1.56
0.42
2.6
3.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
87
1.38
0.42
1.1
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
87
1.38
0.42
1.7
1.7
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
25
203
1.23
0.42
1.2
1.4
pmol/l
67.8
212.8
0.52
14
66
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
24
194
1.24
0.42
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
23
185
1.25
0.41
1.5
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
22
176
1.25
0.41
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
56
491
1.14
0.41
1.8
1.8
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
30
250
1.20
0.40
1.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
60
1.33
0.40
5.5
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
60
1.33
0.40
5.5
2.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
70
625
1.12
0.40
2.0
1.9
iu/l
4.2
4.5
0.08
25
227
(3020876) Protein [Mass/time] in 24 hour Urine
21
168
1.25
0.40
1.9
2.1
—
1.4
—
0
10
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
2.3
2.1
umol/l
20.3
16.2
—
8
61
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.8
1.5
nmol/l
3.5
985192.9
—
5
27
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
19
0.00
0.39
0.0
2.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
14
106
1.32
0.39
1.1
1.1
iu/ml
134.6
209.7
1.15
14
106
(3024263) Appearance of Synovial fluid
14
106
1.32
0.39
1.2
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
67
1.34
0.38
1.3
2.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
98
1.33
0.37
2.3
1.7
—
—
—
0
0
(4281824)
20
246
0.81
0.37
1.1
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
70
1.29
0.36
1.7
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
46
523
0.88
0.35
4.8
4.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
347
1.15
0.35
1.2
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
54
479
1.13
0.35
1.1
1.1
u/ml
2.4
2.8
0.13
15
118
(3008037) Lactate [Moles/volume] in Venous blood
50
442
1.13
0.35
3.6
2.9
mmol/l
1.6
1.6
0.02
50
426
(3008401) Mugwort IgE Ab [Units/volume] in Serum
56
499
1.12
0.34
1.0
1.1
u/ml
0.8
1.3
0.59
23
225
(3008898) HLA-B27 [Presence]
92
1002
0.92
0.34
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
601
5836
1.04
0.34
4.2
4.3
ug/l
2.1
2.4
0.50
543
5269
(3014599) Egg white IgE Ab [Units/volume] in Serum
20
164
1.22
0.32
1.1
1.0
u/ml
0.7
1.0
—
7
43
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
35
402
0.87
0.32
1.3
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
92
1.31
0.31
1.1
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
1.0
1.3
umol/l
19.3
17.0
—
7
47
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
102
1.28
0.30
1.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
1.9
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
10
76
1.32
0.28
1.5
1.3
%
102.4
92.7
—
5
39
(3016750) Collection duration of Urine
16
131
1.22
0.27
2.4
2.1
min
541.6
499.0
0.79
11
97
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
79
730
1.08
0.27
1.6
1.5
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
12
150
0.80
0.27
1.2
1.4
nmol/l
31.9
32.2
0.01
12
130
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
14
113
1.24
0.26
1.3
2.2
ug/l
14.6
308.5
0.70
14
97
(3041806) Other cells [#/volume] in Blood by Manual count
14
113
1.24
0.26
1.5
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
187
1.18
0.26
1.8
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
72
0.69
0.26
1.6
1.6
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
10
77
1.30
0.26
1.6
1.2
%
114.6
111.9
—
10
70
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
328
3391
0.96
0.25
2.9
2.7
ug/l
0.6
0.7
1.16
206
2025
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
245
1.14
0.24
3.4
2.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
142
1.20
0.24
4.6
6.6
—
—
—
0
0
(3035880) pH of Pleural fluid
12
96
1.25
0.24
1.2
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
78
1.28
0.24
3.2
2.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
50
548
0.91
0.24
1.5
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
227
1.15
0.23
1.2
1.2
u/l
50.2
58.6
0.68
20
166
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
20
171
1.17
0.23
1.1
1.2
—
49.6
—
0
9
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
62
572
1.09
0.23
1.1
1.1
u/ml
0.8
1.5
0.78
25
236
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
55
505
1.09
0.23
2.5
2.5
ug/min
92.8
113.8
0.19
28
318
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
41
1.22
0.22
1.2
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
44
401
1.10
0.21
1.0
1.0
u/ml
6.3
4.0
0.34
21
152
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
10
0.00
0.21
0.0
5.0
—
438.5
—
0
10
(3022670) pH of Venous cord blood
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40758358) Immune stain study
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
102
0.78
0.21
1.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
18.5
—
0
13
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
11
89
1.24
0.21
2.2
1.2
%
92.9
107.6
0.80
11
76
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
192
1.15
0.20
1.2
1.2
u/ml
0.2
0.6
—
9
74
(3004775) Volume in Urine collected for unspecified duration
19
164
1.16
0.20
2.3
2.2
ml
844.5
621.5
1.06
14
115
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
15
127
1.18
0.19
1.3
1.1
u/l
8.7
22.8
1.13
15
110
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
42
385
1.09
0.19
1.2
1.1
u/ml
2.6
2.3
0.10
16
185
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
61
569
1.07
0.19
1.3
1.2
—
—
—
0
0
(44813793)
20
175
1.14
0.18
1.0
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
175
1.14
0.18
1.6
1.4
e6/l
28551.0
69995.7
—
10
99
(3049717) Cytology report of Urine Cyto stain
76
716
1.06
0.18
2.1
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2388
23776
1.02
0.18
4.3
4.1
mmol/l
4.7
4.7
0.73
2210
22280
(3023199) Leukocytes [#/volume] in Pleural fluid
23
205
1.12
0.17
1.5
1.3
e6/l
3824.1
1769.1
0.46
16
144
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
215
1.12
0.16
1.5
1.4
mmol/l
10.5
12.0
—
7
49
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
120
1.17
0.16
1.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2372
23625
1.02
0.16
4.2
4.0
mmol/l
1.4
1.5
2.40
2183
22015
(3043410) Blood group antigens tested for on Red Blood Cells
8
73
1.10
0.15
1.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
130
1.15
0.15
2.1
2.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
17
149
1.14
0.15
1.1
1.0
u/ml
0.3
4.0
—
6
21
(3032773) Endomysium IgG Ab [Titer] in Serum
25
226
1.11
0.15
1.2
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
455
4632
0.98
0.15
3.6
3.7
%
21.7
21.2
0.26
191
1956
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
81
1.11
0.15
3.2
2.6
—
—
—
0
0
(4034850)
80
762
1.05
0.14
9.4
9.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
707
6978
1.02
0.14
1.6
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
155
1501
1.03
0.14
1.5
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
170
1.12
0.13
2.6
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2405
24128
0.98
0.13
4.6
4.4
mmol/l
2.8
2.8
1.16
2209
22463
(3045414) Leukocytes [Presence] in Urine
109
1050
1.04
0.13
1.9
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
14
159
0.88
0.13
1.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
116
0.86
0.12
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
44
1.14
0.10
7.8
7.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
48
1.04
0.09
7.8
7.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
42
441
0.95
0.09
1.8
1.4
nmol/l
0.3
0.4
0.38
31
345
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
176
1.08
0.07
2.0
1.8
—
—
—
0
0
(4133840)
8
75
1.07
0.07
1.6
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
76
1.05
0.07
1.3
1.4
ug/l
10.0
8.6
—
8
76
(3047189) Immunofixation for 24 hour Urine
8
91
0.88
0.06
2.9
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
43
413
1.04
0.06
4.0
3.0
mmol/l
7.8
7.4
0.39
43
401
(40765089) Chromosome analysis panel - Blood by G-banded
11
99
1.11
0.06
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
49
478
1.03
0.03
5.1
3.5
mg/l
30.5
24.9
0.34
26
309
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
104
1051
0.99
0.02
1.6
1.7
mg/l
4.2
4.3
0.01
80
734
(4146454)
21
218
0.96
0.02
2.6
2.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
75
740
1.01
0.02
4.1
3.5
u/ml
2792.6
2074.2
0.11
66
636
(3010838) Calcium [Moles/time] in 24 hour Urine
13
123
1.06
0.01
2.2
1.7
—
9.6
—
0
9
(3010144) Erythrocytes [#/volume] in Synovial fluid
22
213
1.03
0.01
1.5
1.3
e6/l
185844.6
103193.6
0.26
15
147
(40761995) Spermatozoa Progressive [#/volume] in Semen
10
99
1.01
0.00
2.9
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
10
99
1.01
0.00
5.8
6.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
165
1.03
0.00
1.6
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
157
1.02
0.00
1.3
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
22
224
0.98
0.00
1.4
1.6
mmol/l
6.7
7.6
0.76
12
135
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
116.0
—
0
5
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
31.6
—
0
5
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
40.1
—
0
5
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
2923.3
—
0
5
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
66
0.91
0.00
2.5
1.5
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
72.6
—
0
5
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
66.1
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
7
70
1.00
0.00
1.3
1.3
%
47.5
52.7
—
7
63
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
2.4
—
0
7
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
94
0.96
0.00
1.0
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
12.3
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
1278.1
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint AB1_VIRAL_CNS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_CNS | 1.972 [1.72, 2.26] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.077 |
During the follow-up period (1.1.1998 — 31.12.2019), 1041 out of 7272 females with AB1_VIRAL_CNS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_CNS | 1.907 [1.66, 2.2] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 1073 out of 7452 males with AB1_VIRAL_CNS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_VIRAL_CNS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.143% | 0.403% |
| 5 | 1.046% | 2.112% |
| 10 | 2.439% | 5.56% |
| 15 | 4.779% | 10.616% |
| 20 | 8.764% | 17.503% |
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_CNS – Viral infections of the central nervous system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data